Companies: 10,795·Total market cap: $144.5T
American Well Corporation

American Well Corporation

AMWLNYSEHealthcare● Active
$8.75
+$0.13(+1.51%)
Market Cap$146199218
P/E Ratio
52W High$9.96
52W Low$3.71
Overview

American Well Corporation (AMWL) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

amwl · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for American Well Corporation (AMWL) measures how much investors pay for each dollar of the company's trailing earnings. AMWL's current PE ratio of N/A is calculated by dividing its stock price of $8.75 by its TTM earnings per share of -$5.30.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-2.49
Based on 2 analysts
EPS (TTM)
-$5.30
TTM · diluted EPS
PEG Ratio
-0.02
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · American Well Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Healthcare Information Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
American Well Corporation
American Well CorporationYou
AMWL
$146MN/A-$5.30
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc.
ADVM
$96MN/A-$6.62
ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc.
ALXO
$211MN/A-$1.90
aTyr Pharma, Inc.
aTyr Pharma, Inc.
ATYR
$43MN/A-$0.80
Biomea Fusion, Inc.
Biomea Fusion, Inc.
BMEA
$68MN/A-$1.18
CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation
CAMP
$87MN/A-$2.65
Precision BioSciences, Inc.
Precision BioSciences, Inc.
DTIL
$87MN/A-$3.63

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-5.96
2024-12-31
FY2024
$-13.88
2023-12-31
FY2023
$-47.50
2022-12-31
FY2022
$-19.72
2021-12-31
FY2021
$-13.88
2020-12-31
FY2020
$-45.32
2019-12-31
FY2019
$-42.39
2018-12-31
FY2018
$-25.96

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for American Well Corporation (AMWL) measures how much investors pay for each dollar of the company's trailing earnings. AMWL's current PE ratio of N/A is calculated by dividing its stock price of $8.75 by its TTM earnings per share of -$5.30.

PE Ratio = Stock Price ÷ EPS (TTM)
= $8.75 ÷ -$5.30 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AMWL pe ratio · 6 questions

AMWL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $8.75 and TTM EPS of -$5.30. Data sourced from Financial Modeling Prep via AMWL's SEC 10-K and 10-Q filings.

AMWL PE ratioWhat is AMWL PE ratioCurrent PE ratio of AMWLAMWL PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · American Well Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09